Evidence map›Paper›PMID 27053631›Full record

ArticleGut2017

Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer.

Gemma Ferrer-Mayorga, Gonzalo Gómez-López, Antonio Barbáchano, Asunción Fernández-Barral, Cristina Peña, David G Pisano, Ramón Cantero, Federico Rojo, Alberto Muñoz, María Jesús Larriba

Open access · hybridAbstract read
In one paragraph

Article in Gut, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 3 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 3 syntheses or guidelines pooled it, 187 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Gemma Ferrer-MayorgaDepartment of Cancer Biology, Instituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.
Gonzalo Gómez-LópezBioinformatics Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre, Madrid, Spain.
Antonio BarbáchanoDepartment of Cancer Biology, Instituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.
Asunción Fernández-BarralDepartment of Cancer Biology, Instituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.
Cristina PeñaDepartment of Medical Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain.
David G PisanoBioinformatics Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre, Madrid, Spain.
Ramón CanteroColorectal Unit, Department of Surgery, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Federico RojoDepartment of Pathology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Madrid, Spain.
Alberto MuñozDepartment of Cancer Biology, Instituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.
María Jesús LarribaDepartment of Cancer Biology, Instituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.
Consejo Superior de Investigaciones Científicas · ESSpanish National Cancer Research Centre · ESUniversidad Autónoma de Madrid · ESHospital La Paz Institute for Health Research · ESHospital Universitario Fundación Jiménez Díaz · ESHospital Universitario Puerta de Hierro Majadahonda · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveColorectal cancer (CRC) is a major health concern. Vitamin D deficiency is associated with high CRC incidence and mortality, suggesting a protective effect of vitamin D against this disease. Given the strong influence of tumour stroma on cancer progression, we investigated the potential effects of the active vitamin D metabolite 1α,25-dihydroxyvitamin D

designExpression of vitamin D receptor (VDR) and two 1,25(OH)

resultsHigh VDR expression in tumour stromal fibroblasts was associated with better overall survival (OS) and progression-free survival in CRC, independently of its expression in carcinoma cells. 1,25(OH)

conclusions1,25(OH)

Indexed as

CalcitriolCancer-Associated FibroblastsCarcinomaCell MovementCells, CulturedCollagenColorectal NeoplasmsDisease-Free SurvivalGene ExpressionHumansKangai-1 ProteinReceptors, CalcitriolS100 Calcium-Binding Protein A4Survival RateTranscriptomeVitaminsCalcitriolCD82 protein, humanCollagenKangai-1 ProteinReceptors, CalcitriolS100A4 protein, humanS100 Calcium-Binding Protein A4VitaminsCOLORECTAL CANCERMYOFIBROBLASTSVITAMIN D RECEPTOR GENE

Identifiers

PMID27053631
PMCPMC5530491
OpenAlexW2339192674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.